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| INTRODUC TI ON
Maternal death is defined as the death of a woman while pregnant or within 42 days of termination of pregnancy from any cause related to or aggravated by pregnancy or its management. 1 Maternal mortality in sub-Saharan Africa is among the highest in the world. 1 Many sub-Saharan African countries, including Mozambique, have a maternal death rate of approximately 500 to 1000 per 100 000 births, compared to approximately 5 to 20 in developed countries. 1, 2 According to the World Health Organization, Mozambique has one of the highest birth rates in the world, and although a substantial reduction of maternal mortality was achieved over the past 20 years, it still has one of the highest maternal mortality rates (500-999 per 100 000 live births). 1, 3 Mortality is especially high in the immediate postpartum period, during which postpartum hemorrhage (PPH) accounts for 30% to 50% of maternal deaths. [4] [5] [6] Over the past decade, substantial efforts have been made in sub-Saharan Africa to implement a variety of preventative measures and treatment protocols to reduce maternal death, resulting in a successful decline in maternal mortality of approximately 40%. 1 However, sub-Saharan Africa continues to have one of the highest maternal mortality rates, and PPH remains a major concern. 1,2 To reduce maternal mortality, it is therefore critical to study the problem of PPH on multiple levels to develop prevention and treatment strategies. A first major step in that direction was achieved with the Women Trial, demonstrating that death from PPH in developing countries can be reduced by approximately 30% if tranexamic acid is administered at the onset of bleeding. 7 This trial demonstrated that simple and relatively inexpensive interventions can impact maternal survival substantially. 8 The prevalence of PPH, and to what extent it varies among sub-Saharan regions, is known only by rough estimation. Local data-gathering and reporting processes that feed into various repositories such as public health registries, surveillance surveys, or national statistical offices are suboptimal. 1, 6, 9 Medical records in sub-Saharan Africa are often incomplete, and training to assess the extent of bleeding may be lacking, especially in rural clinics. 10 Altogether, this may explain discrepancies in reporting between various agencies and also expose uncertainties regarding the accuracy of locoregional numbers. 11 Moreover, the usual definition of PPH (blood loss ≥500 mL during vaginal delivery and ≥1000 mL during cesarean section) may not be clinically relevant in sub-Saharan Africa, where small amounts of blood loss may have detrimental outcomes in patients with preexisting severe (hemoglobin <7 g/d) or moderate anemia (hemoglobin 7-9.9 g/d). Although never formally studied, this is important to note, since the prevalence of maternal anemia approaches 80% in some countries, compared to approximately 5% in the United States. [12] [13] [14] [15] Additionally, there is clinical evidence that anemia can increase the risk of surgical bleeding and PPH. [16] [17] [18] [19] [20] In an effort to target interventions to prevent and treat PPH in Mozambique, we sought to define the rate of PPH and identify risk factors that contribute to PPH and mortality in Maputo Central Hospital, the largest university hospital in Mozambique. We did so formally by extracting data retrospectively from charts of women who delivered during the 6 months from January to June 2018.
Informally, this data review provided much insight regarding local awareness of PPH, PPH assessment measures, and data record keeping, as well as available treatments or a lack thereof. Such assessments are necessary to inform strategies for prospective studies and for improving management of PPH.
| MATERIALS AND METHODS

| Patient population and data extracted
Paper charts from pregnant patients who delivered at Maputo Central Hospital between January and June 2018 were used as data sources for retrospective review. After obtaining permission from the hospital administration, we collected all charts available to us. They came from different areas of the obstetrics/gynecology ward and hospital archive and represented approximately a quarter of all births during this period. This convenience sample was sorted into patients who had spontaneous vaginal deliveries and patients who had cesarean sections. Charts for all the deceased patients during that period, including autopsy reports, were also obtained and examined. One Portuguese-speaking resident obstetrician (MC) and a medical student from the University of California San Diego (LL) worked together to extract information from each patient's file, supervised by the local faculty hematologist and obstetrician (PS and IB).
We extracted basic demographic information on maternal age, estimated gestational age, gravida, parity, and basic labor and delivery information such as vital signs, length of hospitalization, and mode of delivery. We also collected information on complications and comorbidities such as infection with HIV, other known infectious diseases, occurrence of PPH, and survival during hospitalization. If the chart revealed that a mother suffered from a complication during delivery, defined as any unexpected event with the potential to negatively affect maternal and/or fetal health, the delivery was recorded as "complicated." Complete blood counts and basic chemistry values were also extracted, but had been drawn only from patients experiencing complications. For subsequent analyses these patients were named "mothers in distress." Coagulation parameters (activated partial thromboplastin time, prothrombin time, fibrinogen) were not available. Fetal data were limited to infant weight, length, sex, and survival status. Since estimated blood loss was not routinely documented, we determined PPH according to a charted diagnosis of PPH, an intervention for hemorrhaging (including hysterectomy or B-Lynch sutures), a diagnosis of placental abruption, or the need for a blood transfusion.
We used internationally accepted definitions for anemia in pregnancy, thrombocytopenia, and mean cell volume. 21 More specifically, anemia was defined as hemoglobin levels <11 g/dL and divided into mild, moderate, and severe based on a hemoglobin of 10.0 to 10.9 g/dL, 7.0 to 9.9 g/dL, and <7 g/dL, respectively, according to World Health Organization guidelines for pregnant women. 22 The study protocol was approved by the Human Research 
| Statistical methods
Patient characteristics, comorbidities, and complications were expressed as medians and interquartile ranges or as frequencies. Since continuous variables were not normally distributed, we calculated the median and interquartile range for patients who experienced PPH and those who did not. We estimated the median difference between the 2 groups by bootstrapping. 23 For categorical variables we calculated the difference in proportion between patients who bled and those who did not. We tested for trend using the Cochran-Armitage method. 24 Many variables had missing values ( Table 1) . Before fitting regression models, we prepared a complete data set by the sequential multiple regression imputation method, 25 which created 20 imputed replicates. Since our main outcomes of interest-PPH and maternal death-were binary variables, we fitted logistic multiple regression models and calculated odds ratios. The logit was used to estimate the probability of each patient suffering PPH or death. 26 
| RESULTS
| Patient characteristics and comorbidities
Delivery charts of 495 patients were studied, and their characteristics are shown in Table 1 . Median age at delivery was 29 years (range, , and 27% of women were nulliparous. Ten previous births were recorded for 1 patient, but otherwise the maximum was 5. More than half the patients came from the metropolitan area of Maputo, and median gestation length was 39 weeks (range, .
Vital signs were recorded on admission for most patients. The prevalence of HIV was 17%, and malaria was detected in 4 patients. For 58% of deliveries a complication was recorded, including PPH (12%) and (pre)eclampsia (16%). Forty-six percent of the patients underwent a cesarean section.
| Vitals and laboratory values on admission
Blood for complete blood count and basic chemistry on admission was drawn only from mothers in distress (n = 241; Table S1 ). Notably, anemia was present in 54% of cases of mothers in distress, of which 20%, 25%, and 9% had mild, moderate, and severe anemia. Red cell microcytosis (54%) and hypochromia (78%) appeared common, suggesting severe iron deficiency. The prevalence of thrombocytopenia and hypoalbuminemia was 31% and 41%, the latter suggesting a high proportion of mothers in distress, who had underlying malnutrition and/or chronic diseases.
| Parameters associated with PPH
| Demographic variables and comorbidities associated with PPH
The risk of PPH was lowest among mothers in their 20s and then increased with age ( Figure 1A) . PPH further increased steeply with parity ( Figure 1B ). Complicated births, cesarean sections, positive HIV status, and malaria increased the risk of PPH (Table 2) .
Preeclampsia and eclampsia were not associated with PPH, whereas pulse and body temperature measured on admission were higher in women who later experienced PPH. Shorter gestation and lower fetal weight were also associated with greater risk.
Multivariate analyses were run with the imputed data set. We fitted logistic multiple regression models to estimate the risk of PPH in relation to patient variables that were associated with PPH in the univariate analyses and were also recorded on admission, that is, during patient intake. These were parity, HIV status, temperature, and length of gestation. The outcome variable was PPH versus no PPH. The best model showed that increasing parity was associated with a greater risk of PPH, especially for those mothers who already had 3 or more births (adjusted odds ratio [AOR], 7.20; 95% confidence interval [CI], 2.46-21.10 compared to nulliparous mothers) ( Table 3 ). In addition, a shorter gestation and a high temperature on admission were associated with greater risk (Table 3 ). Figure 1C illustrates the estimated risk of PPH according to this model. While
HIV was strongly associated with PPH in the univariate analysis (Table 2) , it was no longer associated with PPH in a model where gestation length and body temperature were also predictors.
In this model (Table 3) , imputation increased the sample size by 56% (495 vs. 318 without imputation), resulting in odds ratios that were a little higher and with narrower 95% CIs (except for temperature), compared to the same model run only on those with complete data.
| Laboratory values on admission as predictors of PPH
Blood tests on admission (available only for distressed patients)
showed that albumin and total protein were both lower in patients who later suffered PPH, while creatinine was elevated (Table S2A; Figure 2 ). Hemoglobin, platelet count, and red blood cell count were all nearly 25% lower in patients who later experienced PPH.
Because anemia appears to influence postpartum bleeding tendency [17] [18] [19] [20] and was found to be profound in many women even prior to developing PPH, we studied the association between PPH and anemia in more detail. We fitted logistic multiple regression models with PPH as the outcome and hemoglobin as the predictor of interest. The objective was to identify the best predictive model for PPH that included hemoglobin as a measure for anemia. We examined age, HIV status, parity, body temperature on admission, and length of gestation as covariates. The best model had just 2 predictors: hemoglobin concentration in grams per deciliter (AOR, 0.62; 95% CI, 0.50-0.77) and gestation length in weeks (AOR, 0.92; 95% CI, 0.85-0.99) ( Table S2B ). The probability of PPH in relation to hemoglobin illustrates how the risk of PPH increased steeply when hemoglobin fell below about 9 g/dL ( Figure 3 ). In other words, moderate and severe anemia were associated with considerably greater risk of PPH than mild anemia. However, the 95% CIs for the predictions increased in width with higher estimated probability of PPH ( Figure 3 ).
| HIV infection and relationship to anemia
The proportion of HIV infection in mothers arriving in distress was more than double that in nondistressed mothers (25% vs. 11%, respectively; percent difference, 14; 95% CI, 7-21). In the distressed mothers, anemia was present in 62% of HIV-infected mothers, compared to 51% in mothers without HIV (percent difference, 12; 95% CI, −3 to 26). The distressed mothers who were positive for HIV had 10.1 g/dL hemoglobin compared to 10.9 g/dL for HIV negative (median difference, −0.95; 95% CI, −2.0 to 0.1). 
| Transfusion management
| Association of PPH with mortality
Thirty-five patients died during hospitalization. The following potential predictors were tested for association with mortality: age, parity, PPH, and infection with malaria or HIV. The frequency of mortality in relation to age was U-shaped, peaking in the <20 years and >40 years age groups ( Figure 4A ). There was no association with parity. PPH and HIV were strongly associated with maternal mortality ( (Table S4 ). Note the very high odds ratio for HIV: The risk of dying was an order of magnitude higher for HIV-positive patients after adjusting for PPH. This is illustrated by Figure 4B : Their median hemoglobin levels were much lower than in mothers who died but did not bleed (10.0 g/dL; median difference, −3.5, 95%
CI, −6.1 to −0.85), and lower than in those who survived PPH (9.2 g/ dL; median difference, −3.0; 95% CI, −5.8 to −0.35) ( Figure S1 ).
| DISCUSSION
We sought to shed light on the prevalence and predictors of PPH as well as associated mortality in Mozambique, one of the world's poorest countries with a known high maternal mortality rate. 1,3 While PPH has been described as a major contributor to maternal mortality Incomplete charting posed a challenge for this study but, importantly, exposed current practices, probably representative for many regions in sub-Saharan Africa. The recognition of local limitations is critical to create opportunities to increase the quality of record keeping and health care provider awareness algorithms and protocols to assess and treat PPH. Wide regional variations in PPH prevalence have been noted in African countries, described in a large meta-analysis by Calvert et al, 31 ranging between approximately 14% to 40% and approximately 0.5% to 15% for blood loss ≥500 and ≥1000 mL, respectively. In contrast, there was little regional variation when comparing several North American studies, where the prevalence for PPH was approximately 10% to 12% and approximately 4% for blood loss ≥500 mL and ≥1000 mL, respectively. 31 The wide variation of PPH recordings in African countries was ascribed to heterogeneity in method and/or timing of blood loss measurement (if any) and locally divergent management practices of delivery. In fact, hemorrhage was defined adequately in only 71 of the 887 studies analyzed, 31 Extensive staff training pertaining to record completeness will be critical on many levels to make an impactful difference for studying PPH and change in medical practice.
In our study, the maternal prevalence of HIV infection was high (17%), similar to a previously reported study performed in metropolitan Maputo. 32 Not unexpectedly, HIV infection was associated with high maternal mortality, also reported by others for this region. 29, 33, 34 Remarkably, though, HIV-related mortality was exacerbated by PPH. The probability of maternal mortality from PPH when the mother was infected with HIV was well over 50%.
Younger mothers (aged <20), and older mothers (aged >40) were at highest risk. Interestingly, HIV status was a risk factor for PPH in univariate analysis but not in multivariate analysis, where body temperature, parity, length of gestation, or the degree of anemia were much stronger predictors of PPH. In part, this may be explained by the fact that parameters such as HIV and body temperature are not independent of each other. Since it is well established that HIV increases the risk of antepartum and intrapartum infection, it is plausible that body temperature was a marker of intrapartum infection, such as chorioamnionitis, which has been shown to facilitate uterine atony and PPH. 35 There is some evidence that body temperature in extreme situations may influence coagulation. 36, 37 However, higher body temperature may also affect uterine contractility, in turn amplifying uterine atony, known to be a major risk factor for PPH. 38 We speculate that the combination of febrile infection in the setting of HIV, paired with higher severity of anemia (compared to HIV-negative patients) may exacerbate PPH, thereby resulting in a high mortality rate. However, a clear understanding of causation will require further investigation in future studies.
Very importantly, anemia on admission to this hospital portended a high risk of subsequent PPH for mothers in distress, a finding that has been observed by others. [17] [18] [19] [20] Here, we demonstrated that the risk of PPH increased inversely with hemoglobin levels for mothers in distress and that, for these subjects, anemia was associated with maternal death. Mothers with PPH who died had much lower hemoglobin concentrations on admission compared to mothers with PPH who survived, indicating a poor tolerance of blood loss when the anemia is severe. While the prevalence of anemia was similar in mothers with and without HIV infection, hemoglobin levels were lower in HIV-infected mothers.
These findings suggest that HIV infection may have contributed at least indirectly to bleeding risk through a greater degree of anemia.
In contrast to other studies originating from higher-developed parts of the world, [39] [40] [41] [42] shorter gestation and lower fetal weight were also associated with a greater risk of PPH. It is possible that premature delivery and/or small infants were a surrogate for poor fetal/maternal health, rendering mothers more vulnerable to PPH.
Further investigations to elucidate this aspect are warranted.
Irrespective of etiology, the notion of anemia and its influence on the risk of bleeding drew our attention and appears interesting on several levels. First, there may be a contribution of altered red cell physiology facilitating bleeding. Preliminary basic scientific studies demonstrate that lower-than-normal red cells in circulation may alter shearing forces, thereby diminishing contact of platelets with the vessel wall and their ability to seal vascular defects. [43] [44] [45] It is conceivable that anemia may render the uterus and/or placenta particularly vulnerable to bleeding since they are highly vascular organs. Second, there is some evidence that the chronic hypoxic environment caused by anemia can upregulate or dysregulate placental vascularity, [46] [47] [48] [49] [50] which may increase the vulnerability of the placenta and uterus to vascular fragility and PPH. Third, anemia has been associated in some studies, 51, 5253 with uterine atony (implicated in PPH 54,55 ), perhaps related to tissue iron deficiency.
Fourth, postpartum blood loss of <500 mL (not meeting the standard definitions of PPH), which is the volume of a blood donation and therefore considered inconsequential for nonanemic individuals, may be poorly tolerated in patients with low hemoglobin levels. Our observations suggest the need to lower the current PPH definition for anemic mothers, perhaps in graded fashion according to anemia severity, to better meet the sub-Saharan situation.
Acute blood loss during delivery also affects subsequent well-being. Postpartum hemorrhage increases the risk of anemia, which may persist for many months or even years after delivery. 56 Blood loss in the setting of preexisting anemia will undoubtedly worsen underlying iron deficiency, which is a major contributor to anemia in the region, 57 as also shown in our cohort by the high prevalence of microcytosis and hypochromia. Since iron deficiency will be difficult to correct given the prevailing nutritional challenges in sub-Saharan Africa, 58 retrospective observation period, only about a quarter of medical charts were available for review (n = 495). The remainder of the charts could not be located or tracked easily, which emphasizes again the regional challenges for data collection. While the availability of charts was not strictly random, it had a random element, since charts were not filed systematically nor were they made available according to specific criteria. We confirmed with the obstetricians that the sample is representative of the overall regional situation, and recorded the main features of the maternal population delivering at Central Maputo Hospital well. This is evidenced by several elements, such as (1) congruency of HIV prevalence with the overall reported regional prevalence, (2) for only approximately half of the study population, namely, mothers in distress. Results in relation to laboratory data may therefore not apply to mothers whose births were uncomplicated. Fourth, mothers who died after leaving the hospital were not recorded due to a general lack of follow-up. Therefore, maternal mortality may have been underestimated.
In conclusion, PPH was found to be a notable yet not well rec- 
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